Acquisitions, biologics, enabling technology and loss of market share by the big players all made our list. Read the specifics and access our projections for 2019 revenue by company and segment.... Read more »
DePuy Synthes and Stryker combined hold more than 50% of the market share in the $7 billion+ trauma segment.... Read more »
You must understand the complexities that define China in order to succeed in business. Dale Tempco, who led R&D for Medtronic Spine and Biologics in China, shares his observations on culture, communication and the orthopedic market. ... Read more »
Billions of dollars separate the top 3 orthopedic device companies from the rest of the pack. Our infographic, built on proprietary knowledge of these companies, details the players and illustrates the gap between #1, DePuy Synthes and #10, Globus Medical.... Read more »
MNVC will feature 22 private companies developing new and emerging technologies in the musculoskeletal hardware, biologics, software and diagnostics spaces.... Read more »
A taskforce comprised of orthopedic competitors and partners is working to create a welding engineering specification, focusing on instruments and an educational component. ... Read more »
FDA's study of new sterilization methods is in response to ethylene oxide sterilization facility closures. The closures were promoted by air quality issues and created a shortage of sterilization options for some medical device companies.... Read more »
Robotics is a priority for the top players in orthopedics. Our infographic highlights the ten robots presently on the market, including launch dates and markets served.... Read more »
AdvaMed named Kevin Lobo, CEO of Stryker, Chairman of the association’s Board of Directors. Lobo's plans during his two-year chairmanship include: patient advocacy, developing pathways to approval and reimbursement for emerging medical technologies and promoting diversity in the industry.... Read more »
Products highlighted here — representing the spine, joint reconstruction, trauma and arthroscopy/soft tissue segments — include a total hip, cervical plate, interbody fusion system, lumbar fusion system, spacer, pedicle screw systems and more. ... Read more »
What else did you read about the most on our website last year? Arthroscopy/soft tissues companies to watch; products in spine, knee and hip; surgeon perspectives on implant material choice; supply chain quality; labelling mistakes, Brazil and more. ... Read more »
Manufacturers recognize the challenge of the skills gap, but far too many fail to change their workforce development and training processes. The report details manufacturers’ trouble areas and identifies best practices for strengthening your team.... Read more »
CEO J. Christopher Barry, hired in November, implemented several changes to NuVasive's executive team to “lead the company’s next phase of growth and innovation.”... Read more »
The companies highlighted here (either brand new or new to us) represent all five major market segments and comprise a broad geographical mix: Denmark, Finland, Israel, Italy, The Netherlands and the United States.... Read more »
David Kay, M.D., a foot/ankle surgeon, shares what he see in his crystal ball regarding plates, biologics and total ankle replacement: "We have a lot of unfinished work. Observe and listen to surgeons, sterile processing, material handlers and supervisors. Suspend your view of the world to see the p... Read more »
In line with the small number of OEM/supplier M&A transactions that have occurred in orthopaedics during the last five years, the deal came about because of a familiarity between the two companies in combination with various market forces.... Read more »
Considering surgical techniques, regulations and technologies together as a whole, expect to see significant changes in orthopaedics over the next decade. Here we present seven shifts that OEMs should consider when choosing new product development initiatives.... Read more »
These polymers have broad orthopaedic application. This article presents a focus on the transition away from Poly-L-lactic acid (PLLA)-type resorbable polymers to updated and novel resorbable biomaterials that are designed to perform better clinically.... Read more »
The spine industry is fixated on two concepts: procedure enhancement via surgical assistance technologies and device design via coatings, materials and manufacturing.... Read more »
We looked at funding, patent and trial/study announcements from January 2017 to June 2018 to see whose initiatives are making waves; many of these companies offer technologies that could make them acquisition or collaboration targets for large OEMs.... Read more »
Medtronic, DePuy Synthes, Stryker and Globus Medical—four of the five largest spine companies ranked by revenue—announced acquisitions in the last month. We recap the additions to their product portfolios.... Read more »
A review of patent activity in 1H18 shows technological innovations from companies like Episurf, iOrthopedics, Orthocell and Spineology across arthroscopy/soft tissue repair, joint reconstruction, orthobiologics, spine and trauma.... Read more »
The OMTEC® 2018 opening Keynote Panel offered perspective on hospital actions and priorities while addressing critical industry topics including pressure from public and private payors, bundled payments, value analysis committees and outpatient surgeries. ... Read more »
We are witnessing the transformation of healthcare - the push to capture cost and outcomes data to support moving from fee-for-service to pay-for-performance medicine. ... Read more »
We examine the players and products, address data and adoption, and look at who is driving the push toward the technology.... Read more »
We asked you to share one piece of advice for 2018 and beyond—we highlight several of your responses and offer some guidance of our own.... Read more »
Of note is the growth of the 20 largest orthopaedic device companies, which combined comprise 76% of the market.... Read more »
The contract manufacturer's second location will produce surgical instruments.... Read more »
The venture covers a wide range of video formats for medical companies to choose from.... Read more »
The company’s new website allows members of the orthopaedic industry to advertise business requirements, find new leads and contacts and grow sales channels.... Read more »
The company is investing nearly $5 million in a new facility that will create up to 60 jobs by 2022.... Read more »
Orthopaedic industry revenue reached $48.1 billion worldwide in 2016 and grew at 3.2%, ~$1.5 billion over 2015, according to our estimates published in the ORTHOPAEDIC INDUSTRY ANNUAL REPORT®. ... Read more »
The unknowns of additive manufacturing have held up some companies from fully committing to its adoption. But, this hasn’t stopped them from progressing and making significant investments. Here's some action from the last few months.... Read more »
First total shoulder procedures and the first U.S. knee revision procedure have now been performed using ExactechGPS, a Guided Personalized Surgery system combining pre-op planning with intra-op real-time computer assistance.... Read more »
Instratek markets staple and hammertoe implants and instrumentation for foot, ankle and upper extremity procedures. The transaction is expected to close in 4Q16.... Read more »
In speaking with Eric Muehlbauer, Executive Director and CEO of NASS about the Society's priorities, as well as where the greatest opportunities lie for surgeons and device companies, three topics arose.... Read more »
Challenges in orthopaedics have created new opportunities to innovate. Here, we look at two: delivery of care and manufacturing techniques.... Read more »
Passage of the "Defend Trade Secrets Act" (DTSA) federalized the trade secret law. One of the key aspects of DTSA is that companies will now be allowed to file civil lawsuits in Federal court if their trade secrets have been stolen, possibly creating a new level of consistency in how trade secret la... Read more »
IK Investment Partners, a European private equity firm, announced that IK VII Fund has reached an agreement to acquire a majority stake in Marle International, an independent implant contract manufacturing company in Europe, from The Carlyle Group.
Carlyle’s Europe Technology fund, majority share... Read more »
Industry trends such as bundled payments, additive manufacturing and robotics were hot topics at this year’s AAOS Annual Meeting.... Read more »
The medical device tax, fought by industry since its inception, was suspended as part of the $1.8 trillion spending and tax bill passed by Congress and signed by President Obama in the waning days of 2015. The 2.3 percent tax on medical device sales received a suspension for 2016 and 2017.... Read more »
In a highly regulated, cost conscious industry, a roadmap to innovation is as important as the type of innovation itself. Companies large and small need to do the following to successfully meet market expectations: allocate money, leverage data and consult FDA.... Read more »
BONEZONE looked back on some of the orthopaedic surgeon interviews conducted throughout the year to see what they had to say about the direction of the industry. Here, we recap four of those insights.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Doug Kohrs wants to be a catalyst for change in the orthopaedic industry as Managing Director of Responsive Orthopedics, a new company that recently received its first 510(k) for a total knee system and is focused on value-based healthcare solutions.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
ichard Randall, recently appointed CEO of OMNI, plans to drive growth by expanding the company’s robotics portfolio and targeting new partners to implement robotic devices for joint surgeries.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Of 2015 OMTEC exhibitors, nearly 20 percent have presented their solutions at the conference since its early days. Discover who these companies are and what they bring to OMTEC year after year.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
How can small companies thrive in the orthopaedic industry? Rod Mayer, President of Nextremity Solutions, shares solutions for success.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Given healthy balance sheets and cheap debt, large and mid-sized buyers are well positioned to pursue acquisition opportunities in 2018 and beyond. CEOs seeking to buy or sell should consider these best practices and expert tips.... Read more »
Experts share their insights on best practices and strategies for conducting clinical trials inside and outside of the U.S., as well as ways to manage outsourcing of the process to a partner.... Read more »
As additive manufacturing gains traction in the orthopaedic industry, device companies must understand business, as well as mechanical, implications over traditional manufacturing.
Orthopaedic device companies, large and small, have adopted additive manufacturing (AM) to varying degrees in implant ... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
If you want a team that will outperform and overcome obstacles, develop these characteristics of an anabolic leader.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »
